Mean Nocturnal Baseline Impedance (MNBI) Provides Evidence for Standardized Management Algorithms of Nonacid Gastroesophageal Reflux-Induced Chronic Cough
(2023)
Journal Article
Zhu, Y., Zhang, T., Wang, S., Li, W., Shi, W., Bai, X., Sha, B., Zhang, M., Wen, S., Shi, C., Xu, X., & Yu, L. (2023). Mean Nocturnal Baseline Impedance (MNBI) Provides Evidence for Standardized Management Algorithms of Nonacid Gastroesophageal Reflux-Induced Chronic Cough. International Journal of Clinical Practice, 2023, Article 7992062. https://doi.org/10.1155/2023/7992062
Background. The clinical management of nonacid gastroesophageal reflux-induced chronic cough (GERC) is challenging, and patient response to standard antireflux therapy (omeprazole 20 mg twice daily plus mosapride 10 mg thrice daily) is suboptimal. Th...
Read More about Mean Nocturnal Baseline Impedance (MNBI) Provides Evidence for Standardized Management Algorithms of Nonacid Gastroesophageal Reflux-Induced Chronic Cough.